Billing Codes

CPT Code 36465: Non-Compounded Foam Sclerotherapy Guide

Key Takeaways

Key Takeaways

CPT Code 36465 covers injection of non-compounded foam sclerosant with ultrasound guidance into a single incompetent extremity truncal vein, imaging inclusive.

The sclerosant drug cost is bundled into reimbursement and must never be billed separately – doing so triggers compliance risk.

Use CPT 36466 when treating multiple incompetent truncal veins in the same session; 36465 and 36466 same-day billing rules vary by payer.

Pabau’s claims management software automates modifier application, ICD-10 pairing, and denial tracking for vascular procedure billing.

Varicose vein claims are among the most frequently denied in outpatient vascular billing. Cosmetic vs. symptomatic distinctions, sclerosant bundling rules, and lateral modifier requirements all create friction between the procedure room and the payer. CPT Code 36465 sits at the center of foam sclerotherapy billing, and getting its descriptor, modifiers, and ICD-10 pairings wrong costs practices real revenue.

This reference covers the complete descriptor for CPT Code 36465, how it compares to adjacent sclerotherapy codes, correct modifier usage, ICD-10 pairing for medical necessity, reimbursement benchmarks, and the documentation requirements payers actually audit. Whether you bill in-office or through a hospital outpatient department, the nuances here determine whether your claim pays on first submission.

CPT Code 36465: Definition and Full Descriptor

CPT Code 36465 is maintained by the American Medical Association (AMA) under the Sclerotherapy of Telangiectasia and Incompetent Veins range (36465-36471). The full official descriptor reads:

Injection of non-compounded foam sclerosant with ultrasound compression maneuvers to guide dispersion of the injectate, inclusive of all imaging guidance and monitoring; single incompetent extremity truncal vein (eg, great saphenous vein, accessory saphenous vein).

Three elements of that descriptor drive every billing decision. First, the sclerosant must be non-compounded foam. Compounded foam or liquid agents require different codes entirely. Second, ultrasound compression maneuvers are required and their documentation supports the inclusive imaging component. Third, the service covers exactly one incompetent truncal vein per session. Treating the great saphenous vein (GSV), small saphenous vein (SSV), anterior accessory great saphenous vein (AAGSV), or posterior accessory great saphenous vein all fall within scope, but only one qualifies for CPT Code 36465 per encounter.

Practices using claims management software can attach CPT Code 36465 to encounters directly from a structured procedure list, reducing transcription errors and ensuring the ICD-10 pairing is validated before submission.

What “Non-Compounded” Means for Billing

The term “non-compounded” is not incidental language. It draws a hard line between FDA-approved commercial foam products and pharmacist-compounded preparations. Varithena (polidocanol injectable foam, 1%) is the primary commercially available non-compounded foam sclerosant used in the United States. When a provider administers Varithena to treat a single incompetent truncal vein under ultrasound guidance, CPT Code 36465 is the correct code.

Compounded foam preparations map to CPT 36470 (single vein, liquid or compounded) or 36471 (multiple veins). Conflating non-compounded and compounded products during billing is a compliance risk flagged in payer audits.

CPT Code 36465 sits within a family of sclerotherapy codes covering different agents, vein counts, and treatment modalities. Choosing correctly among them depends on the sclerosant type and the number of veins treated in a single session. For additional CPT code reference resources across specialties, see Pabau’s procedure code library.

CPT Code Description Sclerosant Type Vein Count
36465 Non-compounded foam sclerosant with ultrasound compression; imaging inclusive Non-compounded foam (eg, Varithena) Single truncal vein
36466 Non-compounded foam sclerosant with ultrasound compression; imaging inclusive Non-compounded foam (eg, Varithena) Multiple truncal veins, same session
36470 Injection of sclerosant, single vein Liquid or compounded foam Single vein
36471 Injection of sclerosant, multiple veins, same leg Liquid or compounded foam Multiple veins
36473 Endovenous ablation, mechanochemical; first vein Mechanochemical (no thermal energy) First vein
36474 Endovenous ablation, mechanochemical; additional vein Mechanochemical Each additional vein
36482 Endovenous ablation, chemical adhesive; first vein Chemical adhesive (eg, cyanoacrylate) First vein
36483 Endovenous ablation, chemical adhesive; additional vein Chemical adhesive Each additional vein

Key distinction: CPT 36465 and 36466 are the only codes reserved for FDA-approved non-compounded foam. CPT 36482 and 36483 cover chemical adhesive ablation (such as cyanoacrylate glue) and also include the adhesive cost in their reimbursement, similar to how 36465 bundles the sclerosant. Billing the drug separately for any of these codes is a payer violation. See related CPT code resources for bundling rule patterns across procedure categories.

Modifiers for Billing CPT Code 36465

Modifier selection for CPT Code 36465 is where many vascular billing teams introduce errors. Bilateral procedures and laterality reporting follow payer-specific rules, and getting them wrong results in either denial or underpayment.

Laterality Modifiers: LT, RT, and 50

When treating one extremity, append modifier RT (right side) or LT (left side) to CPT Code 36465 on a single claim line. When the same procedure is performed on both extremities during the same session, most payers accept one of two approaches:

  • Modifier 50 appended to a single line, billed at the full unit rate (the payer adjusts payment to approximately 150%)
  • Two separate lines, one with LT and one with RT, each at the single-unit rate

Providence Health Services billing policy documents and AAPC guidance indicate that both approaches are used, but payer preference varies. Confirm bilaterality rules with each payer contract before defaulting to one method. Some Medicare Administrative Contractors (MACs) require modifier 50 on a single line; commercial plans like Blue Cross and UnitedHealthcare may require the two-line format. Use your compliance tracking workflow to document each payer’s bilateral rule and flag discrepancies.

36465 and 36466 on the Same Date of Service

CPT Code 36465 (single vein) and CPT 36466 (multiple veins) describe different scopes of service during the same session. Some payers permit both codes when treating one leg. Others allow only one code per leg, regardless of vein count. Before reporting both on the same date, verify the payer’s National Correct Coding Initiative (NCCI) edit status and any applicable Multiple Procedure Payment Reduction (MPPR) policies. Refer to CPT billing guidance for modifier strategy patterns applicable across procedure categories.

According to Providence Health Services’ published billing policy, one service should be reported per leg regardless of how many veins are treated within that leg. This is a common conservative position among regional commercial carriers.

Place of Service

CPT Code 36465 is performed in both office settings (POS 11) and hospital outpatient departments (POS 22). Reimbursement differs: the non-facility rate (office) is higher than the facility rate. When billing from a hospital outpatient department, confirm whether the facility bills the technical component separately and whether a professional component modifier (26) applies to your physician claim.

Pro Tip

Audit your CPT Code 36465 claim lines quarterly. Filter for denials coded as ‘CO-4 service inconsistent with modifier’ or ‘CO-97 payment included in allowance for another service.’ These two denial reasons account for the majority of laterality and bundling errors in foam sclerotherapy billing.

ICD-10 Diagnosis Codes That Support Medical Necessity

No ICD-10 pairing causes more denials for CPT Code 36465 than the cosmetic vs. symptomatic distinction. Payers, including Medicare through CMS Article A52870, maintain a Group 1 code list: claims submitted with these ICD-10 codes are automatically denied as not medically necessary regardless of clinical context. The most common Group 1 codes involve varicose veins coded as cosmetic or uncomplicated.

To support medical necessity for CPT Code 36465, pair the procedure with ICD-10 codes documenting symptomatic or complicated venous disease. The I83 series (varicose veins of lower extremities) provides the primary pairing options. See ICD-10 diagnosis pairing strategies for related coding principles.

ICD-10-CM Code Description Coverage Support
I83.10 Varicose veins of unspecified lower extremity with inflammation Strong – symptomatic
I83.11 Varicose veins of right lower extremity with inflammation Strong – symptomatic
I83.12 Varicose veins of left lower extremity with inflammation Strong – symptomatic
I83.209 Varicose veins of unspecified lower extremity with both ulcer and inflammation Very strong – complicated
I83.009 Varicose veins of unspecified lower extremity with ulcer of unspecified site Very strong – complicated
I83.90 Asymptomatic varicose veins of unspecified lower extremity Risk of denial – cosmetic position

Common mistake: Coding I83.90 (asymptomatic varicose veins) when the patient actually presents with pain, heaviness, or swelling that was not captured in the diagnosis. Always document symptomatic presentation in the clinical note before selecting the ICD-10 code. Per CMS Physician Fee Schedule guidance, medical necessity must be supported by the medical record, not just the code alone.

Reimbursement and Insurance Coverage for CPT Code 36465

CPT Code 36465 reimbursement varies by payer, geographic locality, and place of service. Medicare rates are set annually through the CMS Physician Fee Schedule and should be confirmed for the current fiscal year, as rates change each January 1. The non-facility (office) rate is consistently higher than the facility rate because the practice overhead cost is absorbed by the physician’s practice rather than a hospital outpatient department.

Commercial payers including Blue Cross Blue Shield (multiple regional plans), UnitedHealthcare, and Humana all publish clinical policies listing CPT Code 36465 as a covered service when medical necessity criteria are met. Coverage is generally conditioned on:

  • Documented venous insufficiency confirmed by duplex ultrasound
  • Failure of conservative therapy (compression stockings, typically 6-12 weeks) before intervention
  • Symptomatic presentation (pain, edema, skin changes, or ulceration)
  • Prior authorization where required by the plan (varies by carrier and state)

Cosmetic treatment of varicose veins is explicitly excluded by most payers. When a patient requests sclerotherapy for appearance only, without documented symptoms or functional impairment, CPT Code 36465 is not billable to insurance. The procedure may be offered as a cash-pay service at the practice’s established rate.

Automate Your Vascular Procedure Billing Workflow

Pabau's claims management tools help vascular and phlebology practices link CPT codes to validated ICD-10 pairs, apply modifiers automatically, and track denial patterns before they compound into revenue losses.

Pabau practice management software for vascular billing

Documentation Requirements and Coverage Policies

Payer audits on CPT Code 36465 consistently target three documentation gaps. Addressing these in every clinical note protects reimbursement on initial submission and supports appeal if a claim is denied.

Pre-Procedure Documentation

Clinical records must establish medical necessity before the procedure date. Required elements typically include a duplex ultrasound report confirming venous reflux, a documented trial of conservative therapy (with start and end dates, stockings grade, and patient compliance), and the treating physician’s clinical rationale for intervention. Maintain these records in the patient file and ensure they are retrievable for post-payment audit requests. Using digital intake forms allows structured capture of conservative therapy history and symptom duration at intake, building the medical necessity record before the consultation note is written.

Procedure Note Requirements

The operative note for CPT Code 36465 must document the specific vein treated (name and laterality), the sclerosant agent and formulation confirming it is non-compounded, and a description of the ultrasound compression maneuvers used. Because imaging guidance and monitoring are inclusive in the code, a separate radiology report is not required. However, the ultrasound findings and dispersion guidance steps must appear within the procedure note itself. Refer to your documentation compliance protocols for audit-ready note structure requirements.

Sclerosant Drug Documentation

Because the drug cost is bundled into the reimbursement for CPT Code 36465, the sclerosant must not appear on the claim as a separate line item. However, it must appear in the clinical record: document the drug name (eg, Varithena/polidocanol injectable foam 1%), lot number, dose administered, and route. This supports both compliance and patient safety documentation. According to Priority Health Billing Policy No. 145, separately reporting the sclerosant for 36465 or 36466 is a billing violation.

Pro Tip

Review your EHR or practice management platform’s procedure note template for CPT Code 36465 against your top three payers’ coverage policies. Document the sclerosant product name, lot number, and dose in every note, not just the HCPCS or CPT code line. This one-time template update prevents the most common audit finding in foam sclerotherapy billing.

Billing Workflow: From Documentation to Claim Submission

Effective billing for CPT Code 36465 depends on a structured workflow connecting the clinical encounter to the claim. Gaps at any step compound into denials that cost the practice time and revenue to resolve. The steps below reflect the workflow requirements specific to vascular and phlebology practices billing non-compounded foam sclerotherapy.

  1. Prior authorization: Confirm PA requirements with the patient’s payer before scheduling. PA requirements for CPT Code 36465 vary significantly across carriers and state-specific Medicaid managed care plans. A missing PA is the most common avoidable denial in this code set.
  2. Structured documentation at intake: Capture symptom onset, duration, conservative therapy trial dates, and duplex ultrasound results in a standardized intake form linked to the encounter. This builds the medical necessity file before the procedure date.
  3. Code assignment: Assign CPT Code 36465 for a single truncal vein or CPT 36466 for multiple veins. Confirm the sclerosant is non-compounded foam. Apply LT or RT modifier based on the treated extremity, or modifier 50 for bilateral per payer rules.
  4. ICD-10 pairing: Select the most specific I83 code reflecting the documented clinical condition. Avoid asymptomatic codes when symptoms are present and documented.
  5. Claim scrubbing: Run the claim through your clearinghouse edits to flag NCCI bundling conflicts and missing modifier requirements before transmission.
  6. Denial management: Track denial codes specific to CPT Code 36465. CO-4 (modifier inconsistency), CO-50 (non-covered service), and CO-97 (bundled payment) are the most frequent. Each has a defined appeal pathway.

Practices managing multiple vascular procedures benefit from automated billing workflows that apply code-specific rules at claim generation rather than during a manual review step. Reducing the manual touchpoints between procedure documentation and claim submission cuts denial rates and accelerates payment cycles. For broader vascular procedure documentation, see Pabau’s plastic surgery and procedure-based EMR resources.

Expert Picks

Expert Picks

Need a complete CPT billing reference for vascular procedures? Pabau’s Procedure Code Fee Schedule Guide covers billing structures and fee schedule principles across procedure-based specialties.

Want to reduce claim denials across your practice? Pabau Claims Management Software automates ICD-10 pairing, modifier validation, and denial tracking for vascular and procedure-based billing.

Looking for a structured approach to practice-wide billing compliance? Best Medical Practice Management Software reviews the key features that support compliant billing workflows across specialties.

Conclusion

CPT Code 36465 is a straightforward code with complex billing edges. The sclerosant type, vein count, modifier selection, and ICD-10 pairing all have to align correctly before the claim reaches the payer, and each element is audited independently. Practices that build structured documentation workflows, validate their modifier rules per payer, and track denial patterns by code are the ones that maintain consistent reimbursement on foam sclerotherapy services.

Pabau’s claims management tools are built for exactly this kind of procedure-specific billing: linking CPT codes to validated diagnosis pairs, applying modifiers automatically based on payer rules, and surfacing denial patterns before they accumulate. To see how Pabau handles vascular and procedure-based billing workflows, book a demo with the team.

Frequently Asked Questions

What is CPT Code 36465 used for?

CPT Code 36465 is used to report the injection of a non-compounded foam sclerosant (such as Varithena) into a single incompetent extremity truncal vein, with ultrasound compression maneuvers to guide dispersion. All imaging guidance and monitoring are included in the code. It applies to treatment of the great saphenous vein, small saphenous vein, or accessory saphenous veins.

What is the difference between CPT 36465 and CPT 36466?

CPT 36465 covers treatment of a single incompetent truncal vein using non-compounded foam sclerosant. CPT 36466 covers the same sclerosant type and technique when multiple incompetent truncal veins are treated in the same session. Both codes include imaging guidance. Whether both can be billed on the same date of service depends on payer policy, with some carriers allowing only one code per leg.

Can CPT 36465 be billed with a separate drug code for the sclerosant?

No. The reimbursement for CPT Code 36465 includes the cost of the sclerosant. Separately reporting the foam sclerosant as a drug line item is a billing violation and will be denied or recouped by payers. The drug must be documented in the clinical record but must not appear as a separate claim line.

What modifiers are used with CPT Code 36465?

Modifier RT or LT identifies the treated extremity when treating one leg. For bilateral procedures, modifier 50 is used on a single claim line or two separate lines with LT and RT, depending on payer preference. Medicare Administrative Contractors often require modifier 50 on one line; commercial payers may require the two-line format. Verify each payer’s requirement before billing.

What ICD-10 codes support medical necessity for CPT 36465?

The I83 series (varicose veins of lower extremities with complications) provides the strongest medical necessity support. Codes documenting inflammation (I83.10, I83.11, I83.12), ulceration, or combined findings are preferred over asymptomatic codes. CMS Article A52870 lists ICD-10 codes that will result in automatic denial as not medically necessary when submitted with CPT 36465.

What is the difference between CPT 36465 and CPT 36470?

The key difference is the sclerosant type. CPT 36465 applies specifically to non-compounded foam sclerosants (eg, Varithena). CPT 36470 applies to liquid sclerosants or compounded foam preparations for a single vein. Using 36465 when a compounded agent was administered creates a coding inaccuracy and potential compliance exposure.

×